The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 05, 2017

Filed:

Jul. 06, 2015
Applicant:

Acetylon Pharmaceuticals Inc., Boston, MA (US);

Inventors:

Simon S. Jones, Harvard, MA (US);

Chengyin Min, Brookline, MA (US);

Min Yang, Newton, MA (US);

David Lee Tamang, Watertown, MA (US);

Assignee:
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/4045 (2006.01); A61K 31/706 (2006.01); A61K 45/06 (2006.01); A61K 31/505 (2006.01); A61K 31/5377 (2006.01); A61K 31/496 (2006.01); A61K 31/167 (2006.01); A61K 31/506 (2006.01);
U.S. Cl.
CPC ...
A61K 31/706 (2013.01); A61K 31/167 (2013.01); A61K 31/4045 (2013.01); A61K 31/496 (2013.01); A61K 31/505 (2013.01); A61K 31/506 (2013.01); A61K 31/5377 (2013.01); A61K 45/06 (2013.01);
Abstract

Provided herein are combinations comprising an HDAC inhibitor and azacitidine for the treatment of leukemia in a subject in need thereof. Provided herein are combinations comprising an HDAC inhibitor and azacitidine for the treatment of acute myelogenous leukemia in a subject in need thereof. Also provided herein are methods for treating leukemia in a subject in need thereof, comprising administering to the subject an effective amount of the above combination or an HDAC inhibitor, as well as methods for treating acute myelogenous leukemia in a subject in need thereof, comprising administering to the subject an effective amount of the above combination or an HDAC inhibitor.


Find Patent Forward Citations

Loading…